Practice Patterns and Perspectives of the Off-Label Use of GLP-1 Agonists for Cosmetic Weight Loss
Open accessThe DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.
Abstract
BACKGROUND: The off-label use of glucagon-like peptide 1 (GLP-1) agonists for cosmetic weight loss has captured the interest of the public. However, there is a paucity of published data on their utilization, implications, and management, particularly in the plastic surgery community. OBJECTIVES: This study aims to explore the current practice patterns of aesthetic plastic surgeons regarding the off-label implementation of GLP-1 agonists. METHODS: A 35-question survey was sent to the 2600 members of The Aesthetic Society in July 2023. The survey collected physician demographics, practice settings, patient population demographics, and the use and management of GLP-1 agonists in their practice. No identifying variables were collected; all responses were anonymous. RESULTS: A total of 368 respondents were included. A quarter of respondents (25.3%) prescribed or utilized GLP-1 agonists in their practice. Nearly a third (29.9%) reported personal use of the medication, of which 71 (70.3%) indicated it was for cosmetic weight loss. Many aspects of the current treatment, counseling, and follow-up practices were similar among prescribing plastic surgeons. However, there were discrepancies in screening, nutrition counseling, and perioperative management. The majority believed that GLP-1 agonists were effective for weight loss (68.9%), profitable for business (57.8%), and would recommend its implementation to other plastic surgeons (68.5%). CONCLUSIONS: As leaders in the aesthetic field, it behooves plastic surgeons to take charge of shaping public opinion surrounding the growing off-label use of GLP-1 agonists for cosmetic weight loss. Plastic surgeons' leadership is imperative in establishing safe and ethical guidelines and protocols for proper screening, management, and patient care.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Concerns have been raised about off-label use of compounded GLP-1s [279], including for cosmetic weight reduction [[280], [281], [282], [283]].”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Once-Weekly Semaglutide in Adults with Overweight or Obesity
Wilding, J. P. H., Batterham, R. L., Calanna, S., Davies, M., Van Gaal, L. F., Lingvay, I., McGowan, B. M., Rosenstock, J., Tran, M. T. D., Wadden, T. A., et al. (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2032183 · Cited by 5,205
A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management
Pi-Sunyer, X., Astrup, A., Fujioka, K., Greenway, F., Halpern, A., Krempf, M., Lau, D. C. W., le Roux, C. W., Violante Ortiz, R., Jensen, C. B., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1411892 · Cited by 2,724
Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes
Frías, J. P., Davies, M. J., Rosenstock, J., Pérez Manghi, F. C., Fernández Landó, L., Bergman, B. K., Liu, B., Cui, X., & Brown, K. (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2107519 · Cited by 2,096
The medical care costs of obesity: An instrumental variables approach
Cawley, J., & Meyerhoefer, C. (2012) · Journal of Health Economics · doi:10.1016/j.jhealeco.2011.10.003 · Cited by 1,356
Wilding, J. P. H., Batterham, R. L., Davies, M., Van Gaal, L. F., Kandler, K., Konakli, K., Lingvay, I., McGowan, B. M., Oral, T. K., Rosenstock, J., et al. (2022) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.14725 · Cited by 1,128
Rosenstock, J., Wysham, C., Frías, J. P., Kaneko, S., Lee, C. J., Fernández Landó, L., Mao, H., Cui, X., Karanikas, C. A., & Thieu, V. T. (2021) · The Lancet · doi:10.1016/s0140-6736(21)01324-6 · Cited by 1,080
(2000) · American Journal of Public Health · doi:10.2105/ajph.90.2.251 · Cited by 1,020
Pancreatitis, pancreatic, and thyroid cancer with glucagon-like peptide-1-based therapies
Elashoff, M., Matveyenko, A. V., Gier, B., Elashoff, R., & Butler, P. C. (2011) · Gastroenterology · doi:10.1053/j.gastro.2011.02.018 · Cited by 944
Sorli, C., Harashima, S.-I., Tsoukas, G. M., Unger, J., Karsbøl, J. D., Hansen, T., & Bain, S. C. (2017) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(17)30013-x · Cited by 745
Kalarchian, M. A., Marcus, M. D., Levine, M. D., Courcoulas, A. P., Pilkonis, P. A., Ringham, R. M., Soulakova, J. N., Weissfeld, L. A., & Rofey, D. L. (2007) · American Journal of Psychiatry · doi:10.1176/ajp.2007.164.2.328 · Cited by 616
Obesity and the risk and outcome of infection
Huttunen, R., & Syrjänen, J. (2013) · International Journal of Obesity · doi:10.1038/ijo.2012.62 · Cited by 594
Filippatos, T. D., Panagiotopoulou, T. V., & Elisaf, M. S. (2014) · The Review of Diabetic Studies · Cited by 560
Sodhi, M., Rezaeianzadeh, R., Kezouh, A., & Etminan, M. (2023) · JAMA · doi:10.1001/jama.2023.19574 · Cited by 471
The Psychosocial Burden of Obesity
Sarwer, D. B., & Polonsky, H. M. (2016) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2016.04.016 · Cited by 391
Biliopancreatic diversion for obesity at eighteen years
Scopinaro, N., Gianetta, E., Adami, G. F., Friedman, D., Traverso, E., Marinari, G. M., Cuneo, S., Vitale, B., Ballari, F., Colombini, M., et al. (1996) · Surgery · doi:10.1016/s0039-6060(96)80111-5 · Cited by 390
GLP-1 Receptor Agonists and the Risk of Thyroid Cancer
Bezin, J., Gouverneur, A., Pénichon, M., Mathieu, C., Garrel, R., Hillaire-Buys, D., Pariente, A., & Faillie, J.-L. (2023) · Diabetes Care · doi:10.2337/dc22-1148 · Cited by 320
Glucagon-like peptide-1: a multi-faceted anti-inflammatory agent
Mehdi, S. F., Pusapati, S., Anwar, M. S., Lohana, D., Kumar, P., Nandula, S. A., Nawaz, F. K., Tracey, K., Yang, H., LeRoith, D., et al. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1148209 · Cited by 317
Current status of medical and surgical therapy for obesity
Mun, E. C., Blackburn, G. L., & Matthews, J. B. (2001) · Gastroenterology · doi:10.1053/gast.2001.22430 · Cited by 310
Semlitsch, T., Stigler, F. L., Jeitler, K., Horvath, K., & Siebenhofer, A. (2019) · Obesity Reviews · doi:10.1111/obr.12889 · Cited by 298
Silveira, S. Q., da Silva, L. M., de Campos Vieira Abib, A., de Moura, D. T. H., de Moura, E. G. H., Santos, L. B., Ho, A. M.-H., Nersessian, R. S. F., Lima, F. L. M., Silva, M. V., et al. (2023) · Journal of Clinical Anesthesia · doi:10.1016/j.jclinane.2023.111091 · Cited by 259
Surgeon Sex and Long-Term Postoperative Outcomes Among Patients Undergoing Common Surgeries
Wallis, C. J. D., Jerath, A., Aminoltejari, K., Kaneshwaran, K., Salles, A., Coburn, N., Wright, F. C., Gotlib Conn, L., Klaassen, Z., Luckenbaugh, A. N., et al. (2023) · JAMA Surgery · doi:10.1001/jamasurg.2023.3744 · Cited by 258
COMPLICATIONS OF SURGERY FOR OBESITY
Byrne, T. K. (2001) · Surgical Clinics of North America · doi:10.1016/s0039-6109(05)70190-0 · Cited by 248
The Obese Surgical Patient: A Susceptible Host for Infection
Anaya, D. A., & Dellinger, E. P. (2006) · Surgical Infections · doi:10.1089/sur.2006.7.473 · Cited by 241
Obesity: Impediment to Postsurgical Wound Healing
Wilson, J. A., & Clark, J. J. (2004) · Advances in Skin & Wound Care · doi:10.1097/00129334-200410000-00013 · Cited by 228
Brown, E., Wilding, J. P. H., Barber, T. M., Alam, U., & Cuthbertson, D. J. (2019) · Obesity Reviews · doi:10.1111/obr.12841 · Cited by 222
Han, S. H., Safeek, R., Ockerman, K., Trieu, N., Mars, P., Klenke, A., Furnas, H., & Sorice-Virk, S. (2023) · Aesthetic Surgery Journal · doi:10.1093/asj/sjad211 · Cited by 210
Self-citationSemaglutide, delayed gastric emptying, and intraoperative pulmonary aspiration: a case report
Klein, S. R., & Hobai, I. A. (2023) · Canadian Journal of Anesthesia/Journal canadien d'anesthésie · doi:10.1007/s12630-023-02440-3 · Cited by 207
The story of Clostridium botulinum: from food poisoning to Botox
Ting, P. T., & Freiman, A. (2004) · Clinical Medicine · doi:10.7861/clinmedicine.4-3-258 · Cited by 150
Kobori, T., Onishi, Y., Yoshida, Y., Tahara, T., Kikuchi, T., Kubota, T., Iwamoto, M., Sawada, T., Kobayashi, R., Fujiwara, H., et al. (2023) · Journal of Diabetes Investigation · doi:10.1111/jdi.14005 · Cited by 144
Katout, M., Zhu, H., Rutsky, J., Shah, P., Brook, R. D., Zhong, J., & Rajagopalan, S. (2014) · American Journal of Hypertension · doi:10.1093/ajh/hpt196 · Cited by 140
Hu, W., Song, R., Cheng, R., Liu, C., Guo, R., Tang, W., Zhang, J., Zhao, Q., Li, X., & Liu, J. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.927859 · Cited by 127
Safety of Aesthetic Surgery in the Overweight Patient: Analysis of 127,961 Patients
Gupta, V., Winocour, J. S., Rodriguez-Feo, C. L., Bamba, R., Shack, R. B., Grotting, J. C., & Higdon, K. K. “. (2016) · Aesthetic Surgery Journal · doi:10.1093/asj/sjv268 · Cited by 87
Nagae, K., Uchi, H., Morino‐Koga, S., Tanaka, Y., Mari, O. D. A., & Furue, M. (2018) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2018.10.013 · Cited by 78
Exendin-4, a glucagon-like peptide-1 analogue, accelerates diabetic wound healing.
Roan, J.-N., Cheng, H.-N., Young, C., Lee, C.-J., Yeh, M.-L., Luo, C.-Y., Tsai, Y., & Lam, C. (2017) · Journal of Surgical Research · doi:10.1016/j.jss.2016.09.024 · Cited by 57
Risk factors of infected sternal wounds versus sterile wound dehiscence
Fu, R. H., Weinstein, A. L., Chang, M. M., Argenziano, M., Ascherman, J. A., & Rohde, C. H. (2015) · Journal of Surgical Research · doi:10.1016/j.jss.2015.07.045 · Cited by 48
Coombs, D. M., Srivastava, U., Amar, D., Rubin, J. P., & Gusenoff, J. A. (2017) · Plastic & Reconstructive Surgery · doi:10.1097/prs.0000000000003294 · Cited by 48
The Care of Older Women With Early-Stage Breast Cancer: What Is the Role of Surgeon Gender?
Silliman, R. A., Demissie, S., & Troyan, S. L. (1999) · Medical Care · doi:10.1097/00005650-199910000-00009 · Cited by 45
Unraveling Factors Influencing Early Seroma Formation in Breast Augmentation Surgery
Sforza, M., Husein, R., Atkinson, C. J., & Zaccheddu, R. (2016) · Aesthetic Surgery Journal · doi:10.1093/asj/sjw196 · Cited by 45
Body contouring surgery in a massive weight loss patient: An overview
Shrivastava, P., Aditya, A., & Kumar, K. R. (2008) · Indian Journal of Plastic Surgery · doi:10.1055/s-0039-1700482 · Cited by 33
Common Complications and Management After Massive Weight Loss Patient Safety in Plastic Surgery
Beidas, O. E., & Gusenoff, J. A. (2018) · Clinics in Plastic Surgery · doi:10.1016/j.cps.2018.08.013 · Cited by 30
Interest in Plastic Surgery during COVID-19 Pandemic: A Google Trends Analysis
Duggan, R. P., Tran, J. P., & Phillips, L. G. (2020) · Plastic & Reconstructive Surgery Global Open · doi:10.1097/gox.0000000000003268 · Cited by 22
Effect of the COVID-19 Pandemic on Global Interest in Plastic Surgery
Lem, M. R., Kim, J. K., Pham, J. T., & Tang, C. J. (2023) · JPRAS Open · doi:10.1016/j.jpra.2023.05.002 · Cited by 19
Surgical treatment of morbid obesity
Coelho, J. C. U., & Campos, A. C. L. (2001) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/00075197-200105000-00006 · Cited by 18
Kubota, M., Yamamoto, K., & Yoshiyama, S. (2023) · Cureus · doi:10.7759/cureus.46490 · Cited by 16
Cohen, C. M., Chodick, G., Husemoen, L. L. N., Rhee, N. A., Shalev, V., & Karasik, A. (2019) · Diabetes Therapy · doi:10.1007/s13300-019-0583-9 · Cited by 13
Perceived Stress and Interest in Non-Invasive Aesthetic Procedures During the COVID-19 Pandemic
Ramirez, S., Scherz, G., & Smith, H. E. (2022) · Clinical Cosmetic and Investigational Dermatology · doi:10.2147/ccid.s367001 · Cited by 9
Out-of-scope Cosmetic Surgery: A Review of Malpractice Lawsuits against Nonplastic Surgeons
Moura, S. P., Shaffrey, E. C., Lam, C. S., Wirth, P. J., Attaluri, P. K., & Rao, V. K. (2023) · Plastic & Reconstructive Surgery Global Open · doi:10.1097/gox.0000000000004873 · Cited by 9
Cited by
Mozaffarian, D., Agarwal, M., Aggarwal, M., Alexander, L., Apovian, C. M., Bindlish, S., Bonnet, J., Butsch, W. S., Christensen, S., Gianos, E., et al. (2025) · The American Journal of Clinical Nutrition · doi:10.1016/j.ajcnut.2025.04.023 · Cited by 154
Mozaffarian, D., Agarwal, M., Aggarwal, M., Alexander, L., Apovian, C. M., Bindlish, S., Bonnet, J., Butsch, W. S., Christensen, S., Gianos, E., et al. (2025) · Obesity · doi:10.1002/oby.24336 · Cited by 143
Daneshgaran, G., Shauly, O., & Gould, D. J. (2025) · Aesthetic Surgery Journal Open Forum · doi:10.1093/asjof/ojaf056 · Cited by 47
Mozaffarian, D., Agarwal, M., Aggarwal, M., Alexander, L., Apovian, C. M., Bindlish, S., Bonnet, J. P., Butsch, W. S., Christensen, S. M., Gianos, E., et al. (2025) · Obesity Pillars · doi:10.1016/j.obpill.2026.100269 · Cited by 41
McCall, K. L., Mastro, K. A., Casey, R. T., Samana, T. N., Sulicz, E. K., Tso, S. Y., Yalanzhi, E. R., & Piper, B. J. (2025) · Expert Opinion on Drug Safety · doi:10.1080/14740338.2025.2499670 · Cited by 36
Metadata
- Authors
- Han, S. H., Ockerman, K., Furnas, H., Mars, P., Klenke, A., Ching, J., Momeni, A., & Sorice-Virk, S.
- Affiliations
- University of Florida Health (US)
- Stanford University (US)
- University of Florida (US)
- Corresponding author
- Sorice-Virk, Sarah
- Venue
- Aesthetic Surgery Journal
- Publisher
- Oxford University Press (OUP)
- Published
- 2023-12-12
- Volume
- 44
- Issue
- 4
- Pages
- NP279-NP306
- ISSN
- 1090-820X (ISSN-L)
- 1527-330X
- OpenAlex
- W4389627629
- Cited by
- 40
- References
- 47
- Citations by year
- 2026: 15 · 2025: 22 · 2024: 3
- FWCI
- 6.21
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Aesthetic Surgery Journal (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Pharmacology and Obesity Treatment
- Health Sciences › Medicine › Surgery › Body Contouring and Surgery
- Health Sciences › Medicine › Surgery › Bariatric Surgery and Outcomes
- Keywords
- GLP-1 receptor agonists, off-label drug use, clinical practice patterns, physician prescribing behavior, patient screening, nutrition counseling, perioperative care
- MeSH terms
- Humans, Practice Patterns, Physicians', Surgery, Plastic, Weight Loss, Plastic Surgery Procedures, Glucagon-Like Peptide 1, Off-Label Use, Surgeons
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.